Physician

Paul B Griggs, MD

According to 2025 Medicare claims, Paul Griggs, MD (NPI: 1578584264) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is SIGHT PARTNERS PHYSICIANS, P.C. (NPI: 1689674517; TIN: 911719913) and primary practice location at 98125-3114.

Griggs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,022 traditional Medicare patients, billed 43,624 HCPCS/CPT codes, and received $2,245,493 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 2,023 prescription claims across 348 beneficiaries totaling $171,448 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 24 records totaling $3,347. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $85,751 to $171,448. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2015 Medicare payment: $1,803,747 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,218,104 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,289,230 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,403,595 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,465,810 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,204,425 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,285,044 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,902,289 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,309,097 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,245,493 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,09213,371$1,803,747
20161,16515,117$2,218,104
20171,22914,510$2,289,230
20181,35915,057$2,403,595
20191,44715,675$2,465,810
20201,22613,569$2,204,425
20211,33113,815$2,285,044
20221,07715,687$1,902,289
202391939,004$2,309,097
20241,02243,624$2,245,493

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$97K$193K2015 Drug cost: $85,751 (USD; Tot_Drug_Cst)2016 Drug cost: $88,291 (USD; Tot_Drug_Cst)2017 Drug cost: $85,485 (USD; Tot_Drug_Cst)2018 Drug cost: $140,731 (USD; Tot_Drug_Cst)2019 Drug cost: $155,534 (USD; Tot_Drug_Cst)2020 Drug cost: $165,710 (USD; Tot_Drug_Cst)2021 Drug cost: $193,466 (USD; Tot_Drug_Cst)2022 Drug cost: $170,505 (USD; Tot_Drug_Cst)2023 Drug cost: $178,717 (USD; Tot_Drug_Cst)2024 Drug cost: $171,448 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152211,266$85,751
20162391,181$88,291
20172241,139$85,485
20182841,526$140,731
20193181,628$155,534
20203151,772$165,710
20213331,868$193,466
20223082,006$170,505
20233141,828$178,717
20243482,023$171,448

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2901,294$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more585616$110
92014Established patient complete exam of visual system7651,003$81
92134Imaging of retina6661,336$33
92250Photography of the retina8611,056$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine863,180$63,641
LumiganBimatoprost372,165$19,353
CombiganBrimonidine Tartrate/Timolol441,616$11,667
LatanoprostLatanoprost82539,474$9,167
XiidraLifitegrast11330$7,380

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$3,347Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Paul B. Griggs, MD?

Tedicare shows public-source Medicare data for Paul B. Griggs, MD (NPI 1578584264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul B. Griggs, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul B. Griggs, MD?

Paul B. Griggs, MD is linked to SIGHT PARTNERS PHYSICIANS, P.C. (billing NPI 1689674517) in the available physician profile data.

Does Paul B. Griggs, MD have Open Payments data?

Paul B. Griggs, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.